Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?

Eugene Litvak, PhD;Michael C. Long, MD;J. Sanford Schwartz, MD;

Publication

Article

February 1, 2000

The American Journal of Managed Care

February 2000

Volume6

Issue 2

Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?

Author(s):

Eugene Litvak, PhD,Michael C. Long, MD

Download PDF: Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?

Articles in this issue

Barriers to Using Cost-Effectiveness Analysis in Managed Cae Decision Making

Asking Women to See Nurses or Unfamiliar Physicians as Part of Primary Care Redesign

Cost of Treating Influenza in Emergency Department and Hospital Settings

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

Ischemic Stroke: Acute Management and Secondary Prevention

Is Cost-Effectiveness Modeling Useful?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 4th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 4th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 4th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 4th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

September 4th 2025

Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients

Pierantonio Russo, MD Henriette Coetzer, MD Erik M. Hendrickson, PhD Kenneth Boyle, DC Brent Wright, DrPH

September 4th 2025

Care Quality Metrics in Medicare During COVID-19 Pandemic

Jeanette Thornton, MPA Mark Hamelburg, JD Lynn Nonnemaker, PhD Sherzod Abdukadirov, PhD German Veselovskiy, MPP Sari Siegel, PhD

Related Content

September 4th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 4th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 4th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 4th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

September 4th 2025

Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients

Pierantonio Russo, MD Henriette Coetzer, MD Erik M. Hendrickson, PhD Kenneth Boyle, DC Brent Wright, DrPH

September 4th 2025

Care Quality Metrics in Medicare During COVID-19 Pandemic

Jeanette Thornton, MPA Mark Hamelburg, JD Lynn Nonnemaker, PhD Sherzod Abdukadirov, PhD German Veselovskiy, MPP Sari Siegel, PhD

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

Do Not Sell My Information

Terms & Conditions

Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?

Newsletter